Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Tirzepatide's SURMOUNT-MMO trial and retatrutide's TRIUMPH cardiovascular outcomes study are both ongoing, with results expected in 2027-2028
It's the first authorized generic GLP-1 drug to hit the market, and it's considerably more affordable than brand-name Victoza
Common low-dose regimens fall in the range of about 5 mg to 20 mg per day, and occasionally up to 30 mg per day, administered in divided doses or once daily depending on the context
Its been three months, and not only have I dropped 14 pounds, but Im also regular for the first time in YEARS
Research shows protective effects on lean tissue
US$ 21.30
US$ 27.04
US$ 25.30
US$ 23.92
US$ 28.84
US$ 24.21
US$ 25.74
US$ 28.46
US$ 20.73
US$ 22.36
US$ 21.95
